Barbara Pro
Impact in
-
- Lymphoma Diagnosis and Treatment
-
- Viral-associated cancers and disorders
- CAR-T cell therapy research
- Polyomavirus and related diseases
Papers in
- Oncology 8
- Viral-associated cancers and disorders 5
- Polyomavirus and related diseases 2
- CAR-T cell therapy research 2
-
- Lymphoma Diagnosis and Treatment 6
- Co-authors
- Jennifer E. Amengual (6 shared papers)Aaron D. Viny (1 shared paper)Susan E. Bates (1 shared paper)Seda S. Tolu (3 shared papers)Jonathan E. Brammer (2 shared papers)Koji Izutsu (2 shared papers)Eric D. Jacobsen (2 shared papers)Monica Mead (2 shared papers)
- Journals
- Blood (4 papers)Journal of Clinical Oncology (1 paper)JCO Oncology Practice (1 paper)HemaSphere (1 paper)Nature Reviews Clinical Oncology (1 paper)
- Partner nations
- United StatesItalyJapan
In The Last Decade
Barbara Pro
10 papers receiving 42 citations
Peers
Comparison fields: 5 of 15
- Pathology and Forensic Medicine 17
- Oncology 17
- Dermatology 4
- Immunology 9
- Genetics 3
Countries citing papers authored by Barbara Pro
This map shows the geographic impact of Barbara Pro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Pro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Pro more than expected).
Fields of papers citing papers by Barbara Pro
This network shows the impact of papers produced by Barbara Pro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Pro. The network helps show where Barbara Pro may publish in the future.
Co-authors
The 25 scholars most cited alongside Barbara Pro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 12 | |
| 2 | 2024 | 8 | |
| 3 | 2024 | 4 | |
| 4 | 2022 | 4 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 3 | |
| 7 | 2024 | 3 | |
| 8 | 2022 | 3 | |
| 9 | 2025 | 1 | |
| 10 | 2022 | 1 | |
| 11 | 2025 | 0 |
About Barbara Pro
Barbara Pro is a scholar working on Oncology, Pathology and Forensic Medicine, Genetics, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 11 papers that have together received 42 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (6 papers), Viral-associated cancers and disorders (5 papers), Chronic Lymphocytic Leukemia Research (3 papers), Histone Deacetylase Inhibitors Research (2 papers), Polyomavirus and related diseases (2 papers), CAR-T cell therapy research (2 papers), Acute Myeloid Leukemia Research (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (17 citations), Oncology (17 citations), Dermatology (4 citations), Immunology (9 citations) and Genetics (3 citations). Barbara Pro has collaborated with scholars based in United States, Italy and Japan. Frequent co-authors include Jennifer E. Amengual, Aaron D. Viny, Susan E. Bates, Seda S. Tolu, Jonathan E. Brammer, Koji Izutsu, Eric D. Jacobsen, Monica Mead, Jasmine Zain and Lauren Pinter‐Brown. Their work appears in journals such as Blood, Journal of Clinical Oncology, JCO Oncology Practice, HemaSphere and Nature Reviews Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.